Clinical Trials in Los Angeles

Showing 11541-11560 of 14,465 trials

A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C

NCT01087944

This randomized, cross-over, open label study will compare the tolerability and handling of application of peginterferon alfa-2a \[Pegasys\] by autoinjector versus pre-filled syringe in patients with chronic hepatitis C, either on treatment with peginterferon alfa-2a for at least 12 weeks or treatment-naïve for peginterferon alfa-2a. Patients will be randomized to self-injection of 180mcg peginterferon alfa-2a once a week using either an autoinjector or a prefilled syringe for 3 weeks, then switch to use the other method of injection for another 3 weeks. Anticipated time on study treatment is 6 weeks. Target sample size is \<100 patients.

Hepatitis C, Chronic

Hoffmann-La Roche60 participantsStarted Mar 2010

Los Angeles, California, United States • Bradenton, Florida, United States • Orlando, Florida, United States +9 more locations

COMPLETEDPhase 1< 1 mile

A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer

NCT01300533

The goal of this Phase 1 clinical research study is to find the highest safe dose of BIND-014 that can be given in the treatment of patients with advanced or metastatic cancer.

Metastatic CancerCancerSolid Tumors

BIND Therapeutics58 participantsStarted Jan 2011

Scottsdale, Arizona, United States • Greenbrae, California, United States • Los Angeles, California, United States +3 more locations

A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C

A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer

Find Trials by Condition in Los Angeles

Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

AqueSys Microfistula Implant in Refractory Glaucoma

Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence

NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome

Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)